.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Identify first generic entrants

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
Covington
Moodys
Argus Health
Chinese Patent Office
McKinsey
Healthtrust
Baxter
Accenture

Generated: June 23, 2017

DrugPatentWatch Database Preview

Procainamide hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for procainamide hydrochloride and what is the scope of procainamide hydrochloride freedom to operate?

Procainamide hydrochloride
is the generic ingredient in seven branded drugs marketed by Parke Davis, Watson Labs, Ivax Sub Teva Pharms, Parkedale, Ani Pharms Inc, Abraxis Pharm, Idt Australia Ltd, Pharmafair, Warner Chilcott, West-ward Pharms Int, Smith And Nephew, Solopak, Apothecon, Intl Medication, Hospira, Inwood Labs, Ascot, Lederle, Vangard, King Pharms, Panray, Sandoz, Roxane, and Lannett, and is included in seventy-three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for procainamide hydrochloride. Four suppliers are listed for this compound.

Summary for Generic Name: procainamide hydrochloride

Tradenames:7
Patents:1
Applicants:24
NDAs:73
Drug Master File Entries: see list8
Suppliers / Packagers: see list4
Bulk Api Vendors: see list55
Clinical Trials: see list2,254
Patent Applications: see list1,519
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:procainamide hydrochloride at DailyMed

Pharmacology for Ingredient: procainamide hydrochloride

Drug ClassAntiarrhythmic
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon
PRONESTYL-SR
procainamide hydrochloride
TABLET, EXTENDED RELEASE;ORAL087361-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
CAPSULE;ORAL085167-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Apothecon
PRONESTYL
procainamide hydrochloride
CAPSULE;ORAL007335-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Ani Pharms Inc
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
TABLET, EXTENDED RELEASE;ORAL088958-001Dec 2, 1985DISCNNoNo► Subscribe► Subscribe
Apothecon
PRONESTYL
procainamide hydrochloride
TABLET;ORAL017371-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: procainamide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms
PROCANBID
procainamide hydrochloride
TABLET, EXTENDED RELEASE;ORAL020545-002Jan 31, 19965,656,296► Subscribe
King Pharms
PROCANBID
procainamide hydrochloride
TABLET, EXTENDED RELEASE;ORAL020545-001Jan 31, 19965,656,296► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Harvard Business School
Teva
Citi
Julphar
Covington
Dow
Cerilliant
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot